Who owns EFFECTOR THERAPEUTICS INC?
- CUSIP Number: 28202v207
Tip: Access positions for across all investors
Analyze quarterly positions in Effector Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Effector Therapeutics stock
Who bought or sold EFFECTOR THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Armistice Capital | 223k | $3.2M | 100% | Mar 2024 |
|
| Carlyle | 193k | $2.7M | 100% | Mar 2024 |
|
| Vanguard Group | 93k | $1.3M | 100% | Mar 2024 |
|
| Ensign Peak Advisors | 33k | $474k | 100% | Mar 2024 |
|
| Geode Capital Management | 23k | $325k | 100% | Mar 2024 |
|
| Raymond James & Associates | 12k | $178k | 100% | Mar 2024 |
|
| Sea Otter Advisors | 11k | $152k | 100% | Mar 2024 |
|
| Morgan Stanley | 1.6k | $23k | 100% | Mar 2024 |
|
| Tower Research Capital | 1.5k | $22k | 100% | Mar 2024 |
|
| Royal Bank of Canada | 432.00 | $6.0k | 100% | Mar 2024 |
|
| ICA Group Wealth Management | 247.00 | $3.6k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 19.00 | $272.999600 | 100% | Mar 2024 |
|
| Qube Research & Technologies | 3.00 | $42.999900 | 100% | Mar 2024 |
|